Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cells

Blood (2021) 137 (19): 2598–2608.

https://doi.org/10.1182/blood.2020008503

Published: 2021

Includes: Supplemental data

Journal Articles

TLR8 gain of function: a tall surprise

Bertrand Boisson, Jean-Laurent Casanova

Blood (2021) 137 (18): 2420–2422.

https://doi.org/10.1182/blood.2020010463

Published: 2021

Journal Articles

NADPH Oxidase Controls Neutrophil Infiltration in the Lung in Early Response to Fungal Cell Walls Via LTB4

Mary C. Dinauer, MD PhD, Zhimin Song, PhD, Guangming Huang, M.S., Cliff J. Luke, PhD, Regina A. Clemens, MD PhD

Blood (2019) 134 (Supplement_1): 214.

https://doi.org/10.1182/blood-2019-130664

Published: 2019

Journal Articles

Nicotinamide (NAM) Modulates Transcriptional Signature of Ex Vivo Cultured UCB CD34+ Cells (Omidubicel) and Preserves Their Stemness and Engraftment Potential

Tracey Lodie, PhD, Julian Adams, PhD, Dima Yackoubov, Msc, Yair Steinhardt, MSc, Dorit Ashengrau, Adi Bitansky, Alina Maliutina, Sherry Cohen, Boaz Buhenvald, PhD, Moshe Shahor, PhD, Nathan Dinowitz, PhD, Vered Caspi, PhD, Amnon Peled, PhD, Tony Peled, MSc

Blood (2019) 134 (Supplement_1): 3718.

https://doi.org/10.1182/blood-2019-131124

Published: 2019

Journal Articles

Identifying Primary Immune Deficiencies in Patients with Autoimmune Cytopenias

Emma Westermann-Clark, MD, Krisztian Csomos, PhD, Rachel Cruz Nieves, Other, Cristina Meehan, BS, Boglarka Ujhazi, BS, Maryssa Ellison, Jennifer Lynne Root Mayer, MD, Jonathan Metts, MD, Marisol Betensky, MDMPH, Panida Sriaroon, MD, Irmel Ayala, MD, Jolan Walter, MD PhD

Blood (2019) 134 (Supplement_1): 2328.

https://doi.org/10.1182/blood-2019-130289

Published: 2019

Journal Articles

Interferon-alfa2 Treatment of Patients with Polycythemia Vera and Related Neoplasms Impacts Deregulation of Oxidative Stress Genes and Antioxidative Defence Mechanisms. Potential Implications of IFN-Alfa Induced Changes in TP53, NRF2 and CXCR4 for Genomic Instability and CD34+ Mobilisation

Vibe Skov, PhD, Caroline Riley, PhD, Mads Thomassen, PhD, Lasse Kjær, PhD, Thomas Stauffer Larsen, MD PhD, Ole Weis Bjerrum, MD PhD, Torben A Kruse, Hans Carl Hasselbalch, Professor, dr.MD

Blood (2018) 132 (Supplement 1): 4326.

https://doi.org/10.1182/blood-2018-99-112109

Published: 2018

Journal Articles

Crispr/Cas9-Mediated ASXL1 knockout in U937 Human Leukemic Cells Perturbs Myeloid Differentiation

Zhijie Wu, MD, Xin Zhao, MD PhD, Lauren G. Banaszak, BS, Keyvan Keyvanfar, BS, Sachiko Kajigaya, PhD, Neal S. Young, MD

Blood (2016) 128 (22): 1529.

https://doi.org/10.1182/blood.V128.22.1529.1529

Published: 2016

Journal Articles

The Role of NADPH Oxidase 2 in Normal and Malignant Hematopoiesis

Biniam Adane, BS, Haobin Ye, PhD, Shanshan Pei, PhD, Nabilah Khan, PhD, Mohammad Minhajuddin, PhD, Brett M Stevens, PhD, Vadym Zaberezhnyy, Daniel A Pollyea, MD, Craig T Jordan, PhD

Blood (2016) 128 (22): 1079.

https://doi.org/10.1182/blood.V128.22.1079.1079

Published: 2016

Journal Articles

High Efficiency Gene Correction in Hematopoietic Cells By Template-Free Crispr/Cas9 Genome Editing

Frank Schnütgen, PhD, Duran Sürün, Joachim Schwäble, PhD, Ana Tomasovic, PhD, Ralf Kühn, PhD, Stefan Stein, PhD, Nina Kurrle, PhD, Hubert Serve, MD, Erhard Seifried, MD PhD, Harald von Melchner, MD PhD

Blood (2016) 128 (22): 3507.

https://doi.org/10.1182/blood.V128.22.3507.3507

Published: 2016

Journal Articles

Mechanism of Action of Hydroxychloroquine in the Antiphospholipid Syndrome

Nadine Müller-Calleja, PhD, Davit Manukyan, Wolfram Ruf, MD, Karl Lackner, MD

Blood (2016) 128 (22): 5023.

https://doi.org/10.1182/blood.V128.22.5023.5023

Published: 2016

Journal Articles

Cellular Hydration and Oxidation As Phenotype Modifiers in Sickle Cell Anemia

Mary A Risinger, PhD, Neha Dagaonkar, Georgios E Christakopoulos, MD, Jie Liu, PhD, Katie Giger Seu, PhD, Diamantis G Konstantinidis, BSc, PhD, Charles T Quinn, MD, Satheesh Chonat, MD, Clinton H Joiner, MD PhD, Kejian Zhang, MD, Theodosia A Kalfa, MD PhD

Blood (2016) 128 (22): 2446.

https://doi.org/10.1182/blood.V128.22.2446.2446

Published: 2016

Journal Articles

NADPH Oxidase Limits Sterile Inflammation By Modulating IL-1/G-CSF-Driven Neutrophilic Inflammation

Juhi Bagaitkar, PhD, Ivanov Stoyan, Nancy Pech, Gaungming Huang, Mary C. Dinauer, MD PhD

Blood (2014) 124 (21): 458.

https://doi.org/10.1182/blood.V124.21.458.458

Published: 2014

Journal Articles

NADPH Oxidase 2 Is Critical for Heterotypic Neutrophil-Platelet Interactions during Vascular Inflammation

Jing Li, Kyungho Kim, Robert K. Andrews, Jaehyung Cho

Blood (2014) 124 (21): 459.

https://doi.org/10.1182/blood.V124.21.459.459

Published: 2014

Journal Articles

Gene Expression Profiling of CD34+/Lin- Cells of Patients with Chronic Myeloid Leukemia at Diagnosis and after 12 Months of Nilotinib

Alessandra Trojani, Milena Lodola, Barbara Di Camillo, Giuseppe Rossi, MD, Adele Capucci, Alessandra Perego, Enrico Maria Pogliani, MD, Ester Orlandi, MD, Alessandra Iurlo, MD PhD, Simona Malato, Paolo Corradini, MD, Roberto Cairoli, Marco Bregni, Salvatore Artale, Enrica Morra, Ester Pungolino, MD

Blood (2014) 124 (21): 5177.

https://doi.org/10.1182/blood.V124.21.5177.5177

Published: 2014

Journal Articles

A Platform Minigene AAVS1 Targeted Safe Harbor Approach For Genetic Correction Of iPSC Derived From Patients With Each Of The 5 Genetic Forms Of Chronic Granulomatous Disease

Randall K Merling, Ph.D., Colin L Sweeney, Ph.D., Uimook Choi, Ph.D., Aaron Bodansky, Jessica Chu, Ph.D., Debra Long Priel, Douglas B Kuhns, Ph.D., Hongmei Wang, MD, Sam Vasilevsky, Ph.D., Thomas Winkler, MD, Suk See DeRavin, MD, Jizhong Zou, Ph.D., Thomas Leto, Ph.D., Cynthia E. Dunbar, MD, John Gallin, MD, Steven M. Holland, MD, Harry Malech, MD

Blood (2013) 122 (21): 1024.

https://doi.org/10.1182/blood.V122.21.1024.1024

Published: 2013

Journal Articles

Neutrophil Activation In Sickle Cell Disease: Biochemical and Functional Changes At Baseline and During Acute Vaso-Occlusive Crises

Madelyn S. Hanson, PhD, Nancy J. Wandersee, PhD, Martin Hessner, PhD, Kirkwood A. Pritchard, Jr., PhD, Neil Hogg, PhD, Cheryl A. Hillery, MD

Blood (2013) 122 (21): 992.

https://doi.org/10.1182/blood.V122.21.992.992

Published: 2013

Journal Articles

RNA-Seq Expression Profiling of AML Stem Cells Reveals Differential Expression of Lineage Differentiation Markers and Novel Splice Variants.

Benjamin G Vincent, MD, Darshan Singh, MS, Michael Wu, PhD, Sally A. Hunsucker, PhD, Gheath Alatrash, DO, PhD, Kathryn Ruisaard, MS, Pariya Sukhumalchandra, BS, Karen Clise-Dwyer, PhD, Jonathan S Serody, MD, Jan F Prins, PhD, Jeffrey J. Molldrem, M.D., Paul M. Armistead, MD, PhD

Blood (2012) 120 (21): 2502.

https://doi.org/10.1182/blood.V120.21.2502.2502

Published: 2012

Journal Articles

Turnover of Heme-Bound Iron Is Associated with Activation of TLR4 and Chemokine Receptor Pathways in the Peripheral Blood Mononuclear Cell Transcriptome in Sickle Cell Anemia

Eduard J. van Beers, MD, PhD, Yanqin Yang, MS, Susan Yuditskaya, M.D., Nalini Raghavachari, PhD, Gregory J. Kato, M.D.

Blood (2012) 120 (21): 819.

https://doi.org/10.1182/blood.V120.21.819.819

Published: 2012

Journal Articles

Final Report of a Phase II Trial of Vorinostat with Idarubicin and Cytarabine for Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Guillermo Garcia-Manero, Francesco Paolo Tambaro, MD, PhD, Nebiyou Bekele, Hui Yang, Farhad Ravandi, MD, Elias Jabbour, Gautam Borthakur, Tapan Kadia, Marina Konopleva, M.D., Ph.D., Stefan Faderl, MD, Jorge E. Cortes, Mark Brandt, BS, Yumin Hu, PhD, Deborah McCue, Willie Mae Newsome, RN, Sherry Pierce, RN, BS, Marcos DeLima, MD, Hagop M. Kantarjian

Blood (2011) 118 (21): 763.

https://doi.org/10.1182/blood.V118.21.763.763

Published: 2011

Journal Articles

Final Report of a Phase II Trial of Vorinostat, Idarubicin and Cytarabine In Previously Untreated Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

Guillermo Garcia-Manero, MD, Francesco Paolo Tambaro, MD, PhD, Nebiyou Bekele, MD, Elias Jabbour, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Marina Konopleva, MD, PhD, Tapan Kadia, MD, Jorge E. Cortes, Hui Yang, Mark Brandt, BS, Sherry A. Pierce, RN, BS, Willie Mae Newsome, RN, Hagop Kantarjian, MD

Blood (2010) 116 (21): 2189.

https://doi.org/10.1182/blood.V116.21.2189.2189

Published: 2010

NARROW

Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cells

TLR8 gain of function: a tall surprise

NADPH Oxidase Controls Neutrophil Infiltration in the Lung in Early Response to Fungal Cell Walls Via LTB4

Nicotinamide (NAM) Modulates Transcriptional Signature of Ex Vivo Cultured UCB CD34+ Cells (Omidubicel) and Preserves Their Stemness and Engraftment Potential

Identifying Primary Immune Deficiencies in Patients with Autoimmune Cytopenias

Interferon-alfa2 Treatment of Patients with Polycythemia Vera and Related Neoplasms Impacts Deregulation of Oxidative Stress Genes and Antioxidative Defence Mechanisms. Potential Implications of IFN-Alfa Induced Changes in TP53, NRF2 and CXCR4 for Genomic Instability and CD34+ Mobilisation

Crispr/Cas9-Mediated ASXL1 knockout in U937 Human Leukemic Cells Perturbs Myeloid Differentiation

The Role of NADPH Oxidase 2 in Normal and Malignant Hematopoiesis

High Efficiency Gene Correction in Hematopoietic Cells By Template-Free Crispr/Cas9 Genome Editing

Mechanism of Action of Hydroxychloroquine in the Antiphospholipid Syndrome

Cellular Hydration and Oxidation As Phenotype Modifiers in Sickle Cell Anemia

NADPH Oxidase Limits Sterile Inflammation By Modulating IL-1/G-CSF-Driven Neutrophilic Inflammation

NADPH Oxidase 2 Is Critical for Heterotypic Neutrophil-Platelet Interactions during Vascular Inflammation

Gene Expression Profiling of CD34+/Lin- Cells of Patients with Chronic Myeloid Leukemia at Diagnosis and after 12 Months of Nilotinib

A Platform Minigene AAVS1 Targeted Safe Harbor Approach For Genetic Correction Of iPSC Derived From Patients With Each Of The 5 Genetic Forms Of Chronic Granulomatous Disease

Neutrophil Activation In Sickle Cell Disease: Biochemical and Functional Changes At Baseline and During Acute Vaso-Occlusive Crises

RNA-Seq Expression Profiling of AML Stem Cells Reveals Differential Expression of Lineage Differentiation Markers and Novel Splice Variants.

Turnover of Heme-Bound Iron Is Associated with Activation of TLR4 and Chemokine Receptor Pathways in the Peripheral Blood Mononuclear Cell Transcriptome in Sickle Cell Anemia

Final Report of a Phase II Trial of Vorinostat with Idarubicin and Cytarabine for Patients with Newly Diagnosed Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Final Report of a Phase II Trial of Vorinostat, Idarubicin and Cytarabine In Previously Untreated Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only